Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

The combination therapy failed to beat out the company’s other cancer therapy, Opdivo, in patients living with melanomas.

Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...

Finding a clinical trial that is a good fit can be challenging. Here's how to get the most out of your clinical trial search.

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

Universities are scrambling after the National Institutes of Health announced a plan to cut millions of dollars in research ...

Bristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...

Clinical trials can assist you in getting the right treatment for your condition. Before you consider it, here's what you should know.

Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...

For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...

Insilico Medicine ( “Insilico”) , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today ...